Today's Updates

Early PET May Help Tailor Therapy in Hodgkin Lymphoma
Published Date: 13 May 2026

A trial evaluates whether very early FDG PET-guided treatment adaptation after one cycle of brentuximab vedotin-based chemotherapy improves outcomes in Hodgkin lymphoma.

Read More
When Healthcare Chatbots Fall Short of Human Connection
Published Date: 13 May 2026

Researchers report that digital monitoring tools may improve symptom tracking, but nurses face added demands linked to alert verification and patient support.

Read More
No Survival Benefit Seen With Adjuvant Atezolizumab in TNBC
Published Date: 13 May 2026

Triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy do not gain a survival benefit from adding atezolizumab to adjuvant capecitabine, shows trial.

Read More
PRO Data Strengthen Case for Dato-DXd in First-Line TNBC
Published Date: 13 May 2026

Patients treated with datopotamab deruxtecan reported longer preservation of quality of life and physical functioning vs chemotherapy in metastatic TNBC.

Read More
FDA Advisors Split on Regimens for Breast, Prostate Cancers
Published Date: 13 May 2026

The Oncologic Drugs Advisory Committee backed the prostate cancer drug but rejected a novel approach for breast cancer, highlighting challenges in defining clinical meaningfulness.

Read More
Combo Therapy Boosts Early CML Response but Not Long Term
Published Date: 13 May 2026

A phase 3 trial evaluates the efficacy and safety of nilotinib with pegylated interferon alfa-2a in patients with newly diagnosed chronic-phase chronic myeloid leukemia.

Read More
De-escalation Misses the Mark in Inflammatory Breast Cancer
Published Date: 13 May 2026

Amid a de-escalation trend in breast cancer treatment, less than one third of patients with inflammatory breast cancer receive guideline-endorsed trimodal therapy, despite survival benefits.

Read More
QOL Maintained With Giredestrant Combo in Advanced BC
Published Date: 13 May 2026

Giredestrant plus everolimus does not increase treatment burden in advanced breast cancer, new safety and patient-reported outcome data from the evERA BC trial show.

Read More

Latest News


Latest News

News All Time


Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.

2.

Medicaid expansion tied to smaller declines in early-stage cancer detection

3.

When it comes to obesity-related cancers, where you shop for food matters

4.

SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims

5.

enhancing survivors of brain tumors' quality of life.



© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot